The Difference is in The PatchTM
The Difference is Oxytrol®

contactus.asp

Request Samples


U.S. Prescribing Information >> | OXYTROL Highlights >> | OXYTROL Clinical Results >> | Reimbursement Information >>
Frequently Asked Questions >> | Instructions for Your Patients >>

 

 

Frequently Asked Questions (FAQ's)

Questions About Efficacy
How much oxybutynin is delivered daily with OXYTROL?
Tell me more about OXYTROL. How is it made? How large is it?
How long does it take from the first application of OXYTROL to reach the maximum concentration and steady-state concentration of oxybutynin?

Questions About Safety and Tolerability
Why use the transdermal form of delivery?
How well does OXYTROL adhere to the skin for the 3-4 days of use?
Were there any reports of skin irritation with OXYTROL?
What about anticholinergic adverse reactions with OXYTROL?
Is OXYTROL safe to use in severely underweight/overweight patients?
Will the dosing schedule (every 3 to 4 days) make it difficult for patients to remember when to change their patch?
Which patients should not receive OXYTROL?

Questions About Application and Disposal
Where should OXYTROL be applied?
Can my patients bathe, shower, swim, and exercise with OXYTROL?
What should my patients do if OXYTROL comes off?
What if my patients forget to change OXYTROL after 3-4 days?
How do my patients remove adhesive that is left on their skin after they remove a patch?
How do my patients store OXYTROL?
Where can my patients find additional information about OXYTROL?
How are OXYTROL patches disposed of?

How much oxybutynin is delivered daily with OXYTROL?
OXYTROL contains 36 mg of oxybutynin per patch and delivers 3.9 mg of oxybutynin daily when dosed twice weekly.

Tell me more about OXYTROL. How is it made? How large is it?
OXYTROL, a matrix transdermal system, is composed of three layers. The first layer is the backing film, a thin flexible film that provides the matrix system with occlusivity and physical integrity. At the same time, the backing film protects the second layer. The adhesive/drug layer, the second layer, is a cast film of acrylic adhesive that contains the oxybutynin and triacetin (a skin permeation enhancer). The third layer, formed of two overlapping strips, is the release liner. Prior to application, the patient peels off these strips to expose the adhesive/drug layer. Regarding size, OXYTROL is a credit card-size patch, small enough to be applied and worn comfortably. The OXYTROL 3.9 patch is 7.6 cm X 5.7 cm and delivers 3.9 mg of oxybutynin per day.

How long does it take from the first application of OXYTROL to reach the maximum concentration and steady-state concentration of oxybutynin?
In pharmacokinetic studies involving OXYTROL, the maximum oxybutynin concentration was achieved within about 24-48 hours after the first application. Steady-state concentrations are reached during the second application of OXYTROL. The benefit of these pharmacokinetic qualities is that the OXYTROL system is applied only twice weekly, yet it effectively controls the symptoms of OAB.

Why use the transdermal form of delivery?

  • Convenient twice weekly dosing
  • Long lasting
  • Achieves therapeutic levels at less than half the daily dose of oral immediate release oxybutynin
  • Easy to use
  • Easy to wear
  • Discrete and does not limit activities

How well does OXYTROL adhere to the skin for the 3-4 days of use?

  • Consistent adhesion observed in more than 4700 evaluations
    • System falloff was observed in 0.4% of evaluations
    • Partial detachment was observed in 0.7% of evaluations
  • Bathing, swimming, and exercise should not affect adhesion

Were there any reports of skin irritation with OXYTROL?
In safety and efficacy studies, the most common adverse events were related to the application sites (eg, pruritus, erythema). However, most treatment-related adverse events were described as mild or moderate in intensity. Severe application site reactions were reported by 6.4% of OXYTROL-treated patients in Study 1 and by 5.0% of OXYTROL-treated patients in Study 2. Most patients experienced only mild or no skin irritations.

What about anticholinergic adverse reactions with OXYTROL?
The most common anticholinergic symptoms were dry mouth, dry eyes, constipation, and difficulty urinating. With OXYTROL, dry mouth occurred in 9.6% of patients in one pivotal study (versus 8.3% with placebo) and 4.1% of patients in the other (versus 1.7% with placebo). No patients discontinued OXYTROL treatment due to dry mouth. Constipation, abnormal vision, and dysuria (painful urination) occurred in 2% to <5% of patients.

Is OXYTROL safe to use in severely underweight/overweight patients?
No specific studies investigating severely underweight or overweight patients have been conducted.

Will the dosing schedule (every 3 to 4 days) make it difficult for patients to remember when to change their patch?
Patients are provided with a convenient dosing calendar with each carton of OXYTROL. Your patients can also use the application calendar/reminder to help them with their schedule.

Which patients should not receive OXYTROL?
OXYTROL should not be used in patients experiencing urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma or in patients at risk for these conditions. If there is any known hypersensitivity to any component, OXYTROL should be avoided.

Where should OXYTROL be applied?
OXYTROL should be applied to a clean, dry, smooth area of skin on the abdomen, hip, or buttock. The waistline should be avoided to prevent tight clothing from rubbing against OXYTROL. Sites should be rotated with each new application, with at least 7 days between applications in a single spot.

Can my patients bathe, shower, swim, and exercise with OXYTROL?
Yes, they can wear OXYTROL all of the time until it is time to apply a new one. Baths, showers, swimming, and exercise should not affect OXYTROL as long as patients don’t rub the patch as they wash. They should avoid soaking in a hot tub for a long period of time, which can make the patch come off.

What should my patients do if the patch comes off?
If the patch starts to lift off, they should apply a little bit of pressure using the fingertips. OXYTROL is designed to restick. Very rarely will the patch come off completely. If it does, they should try putting the same patch on the same spot. If it sticks firmly all over, they should leave it on. If not, they should take it off and put a new patch on a new spot. No matter what day this happens, patients should continue with the twice-a-week schedule that they have marked on their OXYTROL box.

What if my patients forget to change the patch after 3-4 days?
As soon as they remember, they should remove the old patch and apply a new one to a new spot on their abdomen, hip, or buttock. No matter what day this happens, they should continue with the same twice-a-week schedule for the next patch, even if it means changing the new one before 3-4 days have elapsed.

How do my patients remove adhesive that is left on their skin after they remove a patch?
They should gently soak the affected area with warm water and mild soap, or use a small amount of baby oil to remove any residue. If the rings of adhesive become soiled, they may need to use a medical adhesive removal pad that should be available from a pharmacist. Alcohol or other dissolving liquids (nail polish remover or other solvents) may cause skin irritation and should not be used.

How do my patients store OXYTROL?
They should store OXYTROL at room temperature, 25° C (77° F). Temporary storage between 15°-30° C (59°-86° F) is also permitted. They should also keep OXYTROL and all medications in a safe, secure place out of the reach of children.

[ back to top ]
 

Where can my patients find additional information about OXYTROL?
Additional information may be obtained by calling 1-888-OXYTROL (1-888-699-9765) or visiting the About OXYTROL section of this site.

How are OXYTROL patches disposed of?
The old patch should be removed slowly and carefully to avoid skin damage. The patch will still contain some oxybutynin, so the sticky edges should be folded together and the patch thrown away where children or pets cannot retrieve it.

Instructions for Your Patients >>